Lee Flowers

Lee Flowers appears in our data through filings on HCW Biologics Inc. shares, published by SEC (Form 4). Between 22 July 2021 and 29 July 2026, the trades on record add up to 10 filings.

The open-market record is one-sided, with 6 purchases worth €357k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 3 option exercises. Since January 2026: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €33k. 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 31 July 2026 came the latest disclosure, an open-market purchase for €18k in HCW Biologics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.